OBIMF (Ondine Biomedical) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OBIMF Ondine Biomedical Inc OBIMF
15 GF Score
Price $0.25
GF Value $0.20
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ondine Biomedical Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OBIMF vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, Ondine Biomedical's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Short Percentage of Float falls into.


OBIMF
15GF Score
Ondine Biomedical Inc OBIMF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ondine Biomedical (OBIMF) Overvalued in 2026?

Based on GuruFocus' analysis, Ondine Biomedical stock appears to be overvalued. The current stock price of $0.25 is trading 25% above its estimated GF Value™ of $0.20. GuruFocus considers Ondine Biomedical to be Modestly Overvalued.

Key valuation signals for OBIMF:

  • Short Percentage of Float:
  • GF Value™: $0.20 vs. price of $0.25 (25% above fair value)
  • GF Score™: 15/100 with 9 warning signs

No single metric tells the full story. See the OBIMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ondine Biomedical Business Description

Other Exchanges OBI:UKVF5:Germany
Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
15GF Score

Get the complete analysis for OBIMF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.20
GF Value